Navigation Links
Four Out of Five BioSpain 2012 Participants Identified Genuine Business Opportunities
Date:3/5/2013

MADRID, March 5, 2013 /PRNewswire/ --

A survey reveals visitor satisfaction of 93%, while 97% would be interesting in attending future editions of the fair.

BioSpain 2012, held in Bilbao in September 2012, has strengthened its position as the principal platform for creating business opportunities in Spain's biotechnology sector. A survey by the organisation reveals that 77% of BioSpain 2012 participants identified genuine business opportunities at the event. This aligns with the objectives established by the organisation, which aims for BioSpain to drive the industry in the current adverse economic situation.

As regards general satisfaction, 93% rated the event positively and 88% stated that it had met their expectations; networking was the most highly-valued activity. In fact, partnering at this year's three-day event led to a record 2,775 one-on-one meetings, making it the fifth-largest international event of its type in terms of networking.

Moreover, 97% of those meetings are expected to lead to a second meeting at a later date. Partnering and one-on-one meetings at BioSpain are increasingly viewed as positive because of the technology available to participants; this year more than 643 technologies and products were on offer (22% more than at the previous edition, in 2010).

The survey also provides useful information regarding biotechnology firms' priorities in this adverse economic environment. The main objective of 48% of BioSpain 2012 participants was to identify R&D collaboration opportunities. Other goals were to attract potential clients (46%), learn about the latest trends and technology (32%) and study the competition (26%).

With respect to the future, 97% of participants will consider attending the next edition of BioSpain in 2014 (venue to be determined).

Click on the link below for the survey results: http://www.asebio.com/documents/resultados_encuesta_para_web_asebio.pdf

Further information from:
Lucía Cecilia
Head of Communication at BioSpain 2012 and ASEBIO
Tel:    +34-912109374/10
Mobile: +34-663117293    
e-mail: lcecilia@asebio.com
http://www.asebio.com


'/>"/>
SOURCE BioSpain 2012 Committee Organization
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. BioSpain 2012 is Larger in Terms of Internationalisation and the Number of Exhibitors, Meetings and Visitors
2. CAS Names 2012 SciFinder® Future Leaders in Chemistry Program Participants
3. Carin Grings remains identified by researchers at Uppsala University
4. Genuine Bio-Fuel Clears the Air About Biodiesel In Wake of Recent Turmoil
5. Genuine Bio-Fuel Inc. Notes Sustainable Energy Gets A Much Needed Boost from the President Obama During 2013 Inaugural Address
6. Genuine Bio-Fuel Inc. Expands Operations to Puerto Rico
7. Bentley Receives $1.3M to Advance the Integration of Science and Business
8. Genomas Expands Personalized Medicine Business with Clinical Laboratory Licenses in New York, Florida, California
9. BIOCOM Names Rick Fultz Vice President of Business Development
10. Pamlab Announces Agreement for Sale of Business to Nestle Health Science
11. Local Leaders Convene in Boston to Share Industry Best Practices in Second “Business of Big Data” Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and technical consulting, provides a free webinar on Performing Quality Investigations: ... 2016 at 12pm CT at no charge. , Incomplete investigations are still a ...
Breaking Biology Technology:
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
(Date:5/9/2016)... UAE, May 9, 2016 Elevay ... comes to expanding freedom for high net worth professionals ... in today,s globally connected world, there is still no ... could ever duplicate sealing your deal with a firm ... passports by taking advantage of citizenship via investment programs ...
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
Breaking Biology News(10 mins):